We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

German medical molding specialist Braunform combined two technologies developed in-house to reduce cycle times and optimize ...

There is no FDA-approved generic version of brand-name weight loss drugs since pharmaceutical companies still hold patents on ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell generic versions of the drugs for less than $100. That is according to ...

I called multiple times to transfer a prescription from my old pharmacy to express scripts and each time they told me the hold time was too long so they had to hang up on the old pharmacy and they ...

After hours: September 18 at 6:19 PM EDT Loading Chart for PEN ...